Turning Science into Consumer Brands

Our strategy is to acquire, through purchase or licence, products with proven innovative and relevant claims that have yet to be developed to their commercial potential. These could be, for example:

• Products with successful clinical trials and ideally registrations, that have yet to be introduced into the OTC market.
• Brands that have been successfully launched in one market but whose owners lack the resources and/or experience to develop them internationally.
• Products or brands which, in spite of having a differentiated claim within a specific category, fall outside the corporate strategic agenda of their current owners.

Markets

HBI is operating in most markets around the world with a particular focus on Europe. By using a virtual organisation we are able to develop an entry plan for a specific country by finding the appropriate local expertise whether it be manufacturing, sales or regulatory.

We are always interested in new products and ideas. If you think HBI might be the right partner for you, if you have a product or brand that fits our strategy or you have the operational expertise that could help us introduce a brand into the market, then please contact either Barry Clare or Robert Gilbert at newbusiness@hbi-ltd.com